PuraStat as secondary therapy for hemostasis in Mallory−Weiss syndrome with oral antithrombotic medication
2024

Using PuraStat for Bleeding in Mallory-Weiss Syndrome

Sample size: 1 publication Evidence: low

Author Information

Author(s): Higashino Makoto, Murakami Hidehiro, Hirata Tetsu, Miyaoka Hiroaki

Primary Institution: Department of Internal Medicine Saiseikai Matsuyama Hospital

Hypothesis

Can PuraStat be effective for achieving hemostasis in Mallory-Weiss syndrome when other methods fail?

Conclusion

PuraStat was effective in achieving hemostasis in a patient with Mallory-Weiss syndrome after other methods failed.

Supporting Evidence

  • PuraStat has been used successfully in other types of gastrointestinal bleeding.
  • The patient had multiple lacerations and active bleeding from Mallory-Weiss syndrome.
  • Endoscopic clipping did not achieve hemostasis, but PuraStat did.

Takeaway

If someone is bleeding in their stomach because of vomiting, a special gel called PuraStat can help stop the bleeding when other treatments don't work.

Methodology

The patient was treated with endoscopy and PuraStat was applied after clipping failed to stop the bleeding.

Limitations

This is a single case report, so broader conclusions cannot be drawn.

Participant Demographics

67-year-old man with a history of coronary artery bypass grafting and on antithrombotic medication.

Digital Object Identifier (DOI)

10.1002/deo2.70033

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication